Childress Capital Advisors, LLC Becton Dickinson & CO Transaction History

Childress Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$254.9 - $283.59 $315,311 - $350,800	1,237 New	1,237 $319,000
Q3 2022 Nov 03, 2022	BUY	$51.03 - $264.23 $20,003 - $103,578	392 Added 36.95%	1,453 $328,000
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $30,516 - $35,804	130 Added 13.96%	1,061 $262,000
Q1 2022 May 10, 2022	BUY	$243.64 - $270.48 $17,298 - $19,204	71 Added 8.26%	931 $249,000
Q4 2021 Jan 26, 2022	BUY	$230.08 - $250.94 $6,442 - $7,026	28 Added 3.37%	860 $216,000
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $193,623 - $213,383	832 New	832 $204,000
Q1 2021 May 21, 2021	SELL	$232.09 - $256.88 $87,265 - $96,586	-376 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$221.92 - $245.94 $83,441 - $92,473	376 New	376 $94,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Childress Capital Advisors, LLC with notifications on news.